Seminars in Hematology
Volume 42, Issue 2 , Pages 112-118 , April 2005

Human leukocyte antigen haploidentical hematopoietic stem cell transplantation: Indications and tentative outcomes in Japan

  • Yoshihisa Kodera

      Affiliations

    • Bone Marrow Transplantation Center, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan
    • Corresponding Author InformationAddress correspondence to Yoshihisa Kodera, MD, PhD, Bone Marrow Tranplantation Center, Japanese Red Cross Nagoya First Hospital, 3-35 Michishita-Cho, Nakamura-ku, Nagoya, 453-8511 Japan
    • ,
  • Tetsuya Nishida

      Affiliations

    • Bone Marrow Transplantation Center, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan
    • ,
  • Tatsuo Ichinohe

      Affiliations

    • Department of Hematology/Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
    • ,
  • Hiroo Saji

      Affiliations

    • Nonprofit Organization—HLA Laboratory, Kyoto, Japan

References 

  1. Thomas ED . Karnofsky Memorial Lecture (Marrow transplantation for malignant disease) . J Clin Oncol . 1983;1:517–531
  2. Hirabayashin N , Kodera Y , Matsuyama T , Tanimoto M , Horibe K , Naoe T , et al.   Bone marrow transplantation in 614 patients (Twenty years experience of Nagoya Bone Marrow Transplantation Group (NBMTG)) . Transplant Proc . 1995;27:1380–1382
  3. Storb RI , Thomas ED , Buckner CD , Clift RA , Johnson FL , Fefer A , et al.   Allogeneic marrow grafting for treatment of aplastic anemia . Blood . 1974;43:157–180
  4. Kojima S , Matsuyama T , Kodera Y , Hirabayashi N , Morishima Y , Iwamura H , et al.   Allogeneic bone marrow transplantation in 25 patients with severe aplastic anemia . Acta Haematol Jpn . 1988;51:705–714
  5. Kernan NA , Bartsch G , Ash RC , Beatty PG , Champlin R , Filipovich A , et al.   Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program . N Eng1 J Med . 1993;328:592–602
  6. Kodera Y , Morishima Y , Kato S , Akiyama Y , Sao H , Matsuyama T , et al.   Analysis of 500 bone marrow transplants from unrelated donors (UR-BMT) facilitated by the Japan Marrow Donor Program (Confirmation of UR-BMT as a standard therapy for patients with leukemia and aplastic anemia) . Bone Marrow Transplant . 1999;24:995–1003
  7. Deeg HJ , Seidel K , Casper J , Anasetti C , Davies S , Gajeweski JL , et al.   Marrow transplantation from unrelated donors for patients with severe aplastic anemia who have failed immunosuppressive therapy . Biol Blood Marrow Transplant . 1999;5:243–252
  8. Kojima S , Matsuyama T , Kato S , Kigasawa H , Kobayashi R , Kikuta A , et al.   Outcome of 154 patients with severe aplastic anemia who received transplants from unrelated donors (The Japan Marrow Donor Program) . Blood . 2002;100:799–803
  9. Broxmyer HE , et al.   Human umbilical cord blood is a source of transplantable hematopoietic stem/progenitor cells . Proc Natl Acad Sci U S A . 1989;86:3828–3832
  10. Kato S , Nishihira H , Hara K , Kato K , Takahashi T , Sato N , et al.   Cord blood transplantation and cord blood bank in Japan . Bone Marrow Transplant . 2000;25(suppl 2):S68–S70
  11. Hansen JA , Beatty PG , Anasetti C , Clift RA , Martin PJ , Sanders J , et al.   Treatment of leukemia by marrow transplantation from donors other than HLA genotypically identical siblings . In:  Gale RP ,  Champlin RE editor. Progress in Bone Marrow Transplantation . New York, NY: Liss; 1987;p. 667–676
  12. Horibe K , Yoshida J , Oiwa K , Kodera Y , Iwamura H , Matsuyama T , et al.   Bone marrow transplantation from related donors other than HLA identical siblings in Japanese patients with hematological malignancies . Acta Haematol Jpn . 1990;53:94–102
  13. Gorin NC , Lopez M , Laporte JP , Quittet P , Lesage S , Lemoine F , et al.   Preparation and successful engraftment of purified CD-34+ bone marrow progenitor cells in patients with non-Hodgkin’s lymphoma . Blood . 1995;85:1647–1654
  14. Kato S , Yabe H , Yasui M , Kawa K , Yoshida T , Watanabe A , et al.   Allogeneic hematopoietic transplantation of CD34+ selected cells from an HLA haplo-identical related donor (A long-term follow-up of 135 patients and a comparison of stem cell source between the bone marrow and the peripheral blood) . Bone Marrow Transplant . 2000;26:1281–1290
  15. Hiraoka A , Ohashi Y , Okamoto S , Moriyama Y , Nagao T , Kodera Y , et al.   Phase III study comparing tacrolimus (FK506) with cyclosporine for graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation . Bone Marrow Transplant . 2001;28:181–185
  16. van Rood JJ , Loberiza FR , Zhang MJ , Oudshoorn M , Claas F , Cairo MS , et al.   Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA haploidentical sibling . Blood . 2002;99:1572–1577
  17. Tamaki S , Ichinohe T , Matsuo K , Hamajima N , Hirabayashi N , Dohy H , et al.   Japan Society of Hematopoietic Cell Transplantation (Superior survival of blood and marrow stem cell recipients given maternal grafts over recipients given paternal grafts) . Bone Marrow Transplant . 2001;28:375–380
  18. The Japan Society for Hematopoietic Cell Transplantation Office of Nationwide Survey: The Japan Society for Hematopoietic Cell Transplantation. Annual Report of Nationwide Survey 2004 (in Japanese). Nagoya, Japan, 2004
  19. Morishima Y , Kodera Y , Hirabayashi N , Tanimoto M , Matsuyama T , Horibe K , et al.   Low incidence of acute GVHD in patients transplanted with marrow from HLA-A, B, DR-compatible unrelated donors among Japanese . Bone Marrow Transplant . 1995;15:235–239
  20. Morishima Y , Morishita Y , Tanimoto M , Ohno R , Saito H , Horibe K , et al.   Low incidence of acute graft graft-versus-host disease by the administration of methotrexate and cyclosporine in Japanese leukemia patients after bone marrow transplantation from human leukocyte antigen compatible siblings (Possible role of genetic homogeneity) . Blood . 1989;74:2252–2256
  21. Beatty PG , Clift RA , Mickelson EM , Nisperos BB , Flournoy N , Martin PJ , et al.   Marrow transplantation from related donors other than HLA HLA-identical siblings . N Engl J Med . 1985;313:765–771
  22. Kanda Y , Chiba S , Hirai H , Sakamaki H , Iseki T , Kodera Y , et al.   Allogeneic hematopoietic stem cell transplantation from family members other than HLA-identical siblings over the last decade (1991-2000) . Blood . 2003;102:1541–1547
  23. Sasazuki T , Juji T , Morishima Y , Kinukawa N , Kashiwabara H , Kodera Y , et al.   Importance of HLA class I allele matching for clinical outcome after unrelated donor hematopoietic stem cell transplantation . N Engl J Med . 1998;339:1177–1185
  24. Morishima Y , Sasazuki T , Inoko H , Juji T , Akaza T , Yamamoto K , et al.   The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors . Blood . 2002;99:4200–4206
  25. Nishida T , Murayama T , Hirai H , Okamoto S , Sao H , Hara M , et al.   Phase-2 study of FK506 for GVHD prophylaxis after BMT from HLA DNA typing mismatched unrelated donor . Rinshoketsueki . 2003;44:678; (in Japanese)
  26. Ichinohe T , Maruya E , Saji H . Long-term feto-maternal microkimerism (Nature’s hidden clue for alternative donor hematopoietic cell transplantation) . Int J Hematol . 2002;76:229–237
  27. Ichinohe T , Uchiyama T , Shimazaki S , Matsuo K , Tamaki S , Hino M , et al.   Feasibility of HLA-haploidentical hematopoietic stem cell transplantation between noninherited maternal antigen (NIMA)-mismatched family members linked with long-term fetomaternal microkimerism . Blood . 2004;104:3821–3828
  28. Beatty PG , Clift RA , Mickelson EM , Nisperos BB , Flournoy N , Martin PJ , et al.   Marrow transplantation from related donors other than HLA-identical siblings . N Engl J Med . 1985;313:765–771
  29. Petersdorf EW , Longton GM , Anasetti C , Martin PJ , Mickelson EM , Smith AG , et al.   The significance of HLA-DRB1 matching on clinical outcome after HLA-A,B, DR identical unrelated donor marrow transplantation . Blood . 1995;86:1606–1613
  30. Schmitz N , Bacigalupo A , Hasenclever D , Nagler A , Gluckman E , Clark P , et al.   Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukemia (First results of a randomised multicentre trial of European Group for Blood and Marrow Transplantation) . Bone Marrow Transplant . 1998;21:995–1003
  31. Harada M , Shinagawa K , Kawano T , Kasai M , Sawada H , Nakao S , et al.   Allogeneic peripheral blood stem cell transplantation for standard-risk leukemia. A multicenter pilot study: Japanese experience. Japan blood cell transplantation study group . Bone Marrow Transplant . 1998;21:s54–s56 (suppl 3)
  32. Gluckman E , Rocha V , Arcese W , Michel G , Sanz G , Chan KW , et al.   Factors associated with outcomes of unrelated cord blood transplant (Guidelines for donor choice) . Exp Hematol . 2004;32:397–407
  33. Nishihira H , Kato K , Isoyama K , Takahashi TA , Kai S , Kato S , et al.   The Japanese Cord Blood Bank Network experience with cord blood transplantation from unrelated donors for haematological malignancies (An evaluation of graft-versus-host disease prophylaxis) . Br J Haematol . 2003;120:516–522

PII: S0037-1963(05)00013-2

doi: 10.1053/j.seminhematol.2005.02.001

Seminars in Hematology
Volume 42, Issue 2 , Pages 112-118 , April 2005

Article Tools

* Image Usage & Resolution